Clinical Trial

A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 15, 2025 (before its estimated July 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
The Phase 1 clinical trial of the freeze-dried human rabies vaccine (human diploid cells) will be conducted on participants aged 10 to 60. This study will design a single-arm, randomized, open-access trial with different immunization schedules (5-dose schedule and 2-1-1 schedule) to evaluate the safety and tolerability of the vaccine in participants aged 10 to 60
Trial Details
NCT Number NCT07021703
Lead Sponsor Ningbo Rongan Biological Pharmaceutical Co., Ltd.
Conditions Rabies
Enrollment 60 participants
Start Date 2025-05-23
Primary Completion 2025-07-28 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-15